Simcere Pharmaceutical (SCR): Q4 Preliminary EPS of -$0.06. Preliminary Revenue of $86.7M (+5.7%...

|About: Simcere Pharmaceutical G... (SCR)|By:, SA News Editor
Simcere Pharmaceutical (SCR): Q4 Preliminary EPS of -$0.06. Preliminary Revenue of $86.7M (+5.7% Y/Y). (PR)